News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News ESC 2024 More Data Diminish Support for Cath Lab Fasting Rules: SCOFF L.A. McKeown September 10, 2024
News Conference News LINC 2023 What Works, What’s Noise? Novel Approaches Offer Hope in CLTI L.A. McKeown June 07, 2023
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News TCT 2021 ‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients Yael L. Maxwell November 04, 2021
News Conference News ESC 2020 EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF Michael O'Riordan August 28, 2020
News Conference News ACC 2020 Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes Yael L. Maxwell March 30, 2020
News Conference News ISET 2019 Eluvia Sustains Lead Over Zilver PTX in Patients With Diabetes: IMPERIAL Subanalysis Caitlin E. Cox January 30, 2019
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News EuroPCR 2017 BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI Michael O'Riordan May 18, 2017
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011